Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal intelligence from Strategic Transactions.
Antisense therapy-focused Ionis Pharmaceuticals Inc. announced a pair of licensing deals in recent weeks – with Dynacure SAS and...








